| Name | Visionworks |
|---|---|
| Organization Name | Visionworks Inc |
| Location | 1605 1st St S, Willmar, Minnesota 56201 |
| Type | Eyewear Supplier (Equipment, not the service) |
| Phone | (320) 235-9060 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
People suffering from type 2 diabetes and cardiovascular disease are at an increased risk of cognitive decline, according to a new study from Wake Forest Baptist Medical Center.
Bristol-Myers Squibb Company (NYSE: BMY) announced today that it has extended its previously announced cash tender offer, through its wholly-owned subsidiary, Puma Acquisition Corporation, to purchase all outstanding shares of common stock of Medarex (NASDAQ: MEDX) ("Medarex") until 12:00 midnight (New York City time) on August 26, 2009, unless further extended.
Apricus Biosciences, backed by a revenue generating CRO business and seeking to leverage its multi-route NexACT® drug delivery technology and internal pipeline through out-licensing partnerships, today announced that the Company has closed its previously announced securities offering, raising over $9.3 million in gross proceeds. Apricus Bio intends to use the proceeds from this offering for product and technology development and general corporate purposes. Dawson James Securities acted as the exclusive placement agent for the offering.
Scientists from MIPT's Laboratory of the Biophysics of Excitable Systems have discovered how to control the behaviour of heart muscle cells (cardiomyocytes) using laser radiation; this study will help scientists to better understand the mechanisms of the heart and could ultimately provide a method of treating arrhythmia. The paper has been published in the journal PLOS ONE.
› Verified 8 days ago
| NPI Number | 1336224245 |
| Organization Name | VISION WORLD INC |
| Doing Business As | VISION WORLD |
| Type | Eyewear Supplier (Equipment, not the service) |
| Address | 1605 South 1st Street, Willmar, MN 56201 |
| Phone Number | 320-235-9060 |
News Archive
People suffering from type 2 diabetes and cardiovascular disease are at an increased risk of cognitive decline, according to a new study from Wake Forest Baptist Medical Center.
Bristol-Myers Squibb Company (NYSE: BMY) announced today that it has extended its previously announced cash tender offer, through its wholly-owned subsidiary, Puma Acquisition Corporation, to purchase all outstanding shares of common stock of Medarex (NASDAQ: MEDX) ("Medarex") until 12:00 midnight (New York City time) on August 26, 2009, unless further extended.
Apricus Biosciences, backed by a revenue generating CRO business and seeking to leverage its multi-route NexACT® drug delivery technology and internal pipeline through out-licensing partnerships, today announced that the Company has closed its previously announced securities offering, raising over $9.3 million in gross proceeds. Apricus Bio intends to use the proceeds from this offering for product and technology development and general corporate purposes. Dawson James Securities acted as the exclusive placement agent for the offering.
Scientists from MIPT's Laboratory of the Biophysics of Excitable Systems have discovered how to control the behaviour of heart muscle cells (cardiomyocytes) using laser radiation; this study will help scientists to better understand the mechanisms of the heart and could ultimately provide a method of treating arrhythmia. The paper has been published in the journal PLOS ONE.
› Verified 8 days ago
| NPI Number | 1346527082 |
| Organization Name | VISIONWORKS, INC. |
| Doing Business As | VISIONWORKS |
| Type | Eyewear Supplier (Equipment, not the service) |
| Address | 1605 1st St S, Willmar, MN 56201 |
| Phone Number | 320-235-9060 |
News Archive
People suffering from type 2 diabetes and cardiovascular disease are at an increased risk of cognitive decline, according to a new study from Wake Forest Baptist Medical Center.
Bristol-Myers Squibb Company (NYSE: BMY) announced today that it has extended its previously announced cash tender offer, through its wholly-owned subsidiary, Puma Acquisition Corporation, to purchase all outstanding shares of common stock of Medarex (NASDAQ: MEDX) ("Medarex") until 12:00 midnight (New York City time) on August 26, 2009, unless further extended.
Apricus Biosciences, backed by a revenue generating CRO business and seeking to leverage its multi-route NexACT® drug delivery technology and internal pipeline through out-licensing partnerships, today announced that the Company has closed its previously announced securities offering, raising over $9.3 million in gross proceeds. Apricus Bio intends to use the proceeds from this offering for product and technology development and general corporate purposes. Dawson James Securities acted as the exclusive placement agent for the offering.
Scientists from MIPT's Laboratory of the Biophysics of Excitable Systems have discovered how to control the behaviour of heart muscle cells (cardiomyocytes) using laser radiation; this study will help scientists to better understand the mechanisms of the heart and could ultimately provide a method of treating arrhythmia. The paper has been published in the journal PLOS ONE.
› Verified 8 days ago
News Archive
People suffering from type 2 diabetes and cardiovascular disease are at an increased risk of cognitive decline, according to a new study from Wake Forest Baptist Medical Center.
Bristol-Myers Squibb Company (NYSE: BMY) announced today that it has extended its previously announced cash tender offer, through its wholly-owned subsidiary, Puma Acquisition Corporation, to purchase all outstanding shares of common stock of Medarex (NASDAQ: MEDX) ("Medarex") until 12:00 midnight (New York City time) on August 26, 2009, unless further extended.
Apricus Biosciences, backed by a revenue generating CRO business and seeking to leverage its multi-route NexACT® drug delivery technology and internal pipeline through out-licensing partnerships, today announced that the Company has closed its previously announced securities offering, raising over $9.3 million in gross proceeds. Apricus Bio intends to use the proceeds from this offering for product and technology development and general corporate purposes. Dawson James Securities acted as the exclusive placement agent for the offering.
Scientists from MIPT's Laboratory of the Biophysics of Excitable Systems have discovered how to control the behaviour of heart muscle cells (cardiomyocytes) using laser radiation; this study will help scientists to better understand the mechanisms of the heart and could ultimately provide a method of treating arrhythmia. The paper has been published in the journal PLOS ONE.
› Verified 8 days ago
Cvs Pharmacy #16188 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2505 1st St S, Willmar, Minnesota 56201 Phone: (320) 235-3026 | |
Medical Supplies, Inc. Type: Durable Medical Equipment & Medical Supplies Supplier Location: 312 4th St Sw, Willmar, Minnesota 56201 Phone: (320) 231-3655 | |
Wal-mart Pharmacy 10-1470 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 700 19th Ave Se, Willmar, Minnesota 56201 Phone: (320) 231-3313 | |
Thrifty White Pharmacy #022 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2300 1st S St, Willmar, Minnesota 56201 Phone: (320) 235-1930 | |
Cub Pharmacy # 1607/704 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2201 1st St S, Willmar, Minnesota 56201 Phone: (320) 214-8502 |